Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
Loading...
Date
2022-02-25
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Tropical Medicine and Health
Abstract
Primaquine is a gametocytocidal drug known to significantly reduce malaria transmission. However, primaquine induces a dose-dependent acute hemolytic anemia (AHA) in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency that has led to a limited use of the drug especially in Africa where the condition is common. The World Health Organization (WHO) now recommends a single low dose (SLD) of primaquine (0.25 mg/kg) as P. falci-parum gametocytocidal without the need for prior screening of G6PD status. Adoption and implementation of SLD primaquine in Africa may probably reduce malaria transmission, a pre-requisite for malaria elimination. This review therefore, focused on the safety of primaquine for control of malaria in Africa. The literature search was performed using online database Google Scholar, PubMed, HINARI, and Science Direct. Search terms used were “malaria”, “pri-maquine”, “safety”, “G6PD deficiency”, “large scale” or “mass administration”. Clinical trials in many African countries have shown SLD primaquine to be safe especially in a milder African G6PD A- variant. Likewise, large-scale primaquine administrations outside Africa involving hundreds of thousands to tenths of millions of participants and with severe variants of G6PD deficiency have also shown primaquine to be safe and well-tolerated. Fourteen deaths associated with primaquine have been reported globally over the past 6 decades, but none occurred following the administra-tion of SLD primaquine. Available evidence shows that the WHO-recommended SLD primaquine dose added to effec-tive schizonticides is safe and well-tolerated even in individuals with G6PD deficiency, and therefore, it can be safely used in the African population with the mildest G6PD A- variant.
Description
Keywords
Malaria, Primaquine, G6PD deficiency
Citation
Mwaiswelo, R.O., Kabuga, H., Kweka, E.J. and Baraka, V., 2022. Is it time for Africa to adopt primaquine in the era of malaria control and elimination?. Tropical Medicine and Health, 50(1), pp.1-13.